Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Haotian Liu, Qiuying Dai, Yixian Li, Zhenfei Tang & Tiantian She. (2023) Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis. Hematology 28:1.
Read now
Read now
Cosimo Cumbo, Luisa Anelli, Giorgina Specchia & Francesco Albano. (2020) Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances. Cancer Management and Research 12, pages 3175-3189.
Read now
Read now
Eli Muchtar, Angela Dispenzieri, Dragan Jevremovic, David Dingli, Francis K. Buadi, Martha Q. Lacy, Wilson Gonsalves, Rahma Warsame, Taxiarchis V. Kourelis, Suzanne R. Hayman, Prashant Kapoor, Nelson Leung, Stephen Russell, John A. Lust, Yi Lin, Ronald S. Go, Steven Zeldenrust, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar & Morie A. Gertz. (2020) Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis. Amyloid 27:1, pages 13-16.
Read now
Read now
Victor Valdespino & Patricia M Valdespino. (2015) Potential of epigenetic therapies in the management of solid tumors. Cancer Management and Research 7, pages 241-251.
Read now
Read now
Articles from other publishers (15)
Simona Bernardi, Michele Malagola, Mirko Farina, Nicola Polverelli, Federica Re & Domenico Russo. (2022) Digital PCR as a New Method for Minimal Residual Disease Monitoring and Treatment Free Remission Management in Chronic Myeloid Leukemia Patients: Is It Reliable?. Hemato 4:1, pages 1-11.
Crossref
Crossref
Xin Xu, Ao Huang, De-Zhen Guo, Yu-Peng Wang, Shi-Yu Zhang, Jia-Yan Yan, Xin-Yu Wang, Ya Cao, Jia Fan, Jian Zhou, Xiu-Tao Fu & Ying-Hong Shi. (2022) Integration of Inflammation-Immune Factors to Build Prognostic Model Predictive of Prognosis and Minimal Residual Disease for Hepatocellular Carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Yassmine M. N. Akkari, Linda B. Baughn, Adrian M. DubucAdam C. Smith, Mar Mallo, Paola Dal Cin, Maria Diez Campelo, Marta S. GallegoIsabel Granada Font, Detlef T. HaaseBrigitte Schlegelberger, Irma Slavutsky, Cristina Mecucci, Ross L. LevineRobert P. Hasserjian, Francesc Solé, Brynn Levy & Xinjie Xu. (2022) Guiding the global evolution of cytogenetic testing for hematologic malignancies. Blood 139:15, pages 2273-2284.
Crossref
Crossref
Haeyoung Kim, Yeon Jeong Kim, Donghyun Park, Woong-Yang Park, Doo Ho Choi, Won Park, Won kyung Cho & Nalee Kim. (2021) Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study. Breast Cancer Research and Treatment 189:1, pages 167-175.
Crossref
Crossref
Araceli Diez-Fraile, Joke De Ceulaer, Charlotte Derpoorter, Christophe Spaas, Tom De Backer, Philippe Lamoral, Johan Abeloos & Tim Lammens. (2020) Circulating Non-Coding RNAs in Head and Neck Cancer: Roles in Diagnosis, Prognosis, and Therapy Monitoring. Cells 10:1, pages 48.
Crossref
Crossref
Kai-Qian Zhou, Yun-Fan Sun, Jian-Wen Cheng, Min Du, Yuan Ji, Peng-Xiang Wang, Bo Hu, Wei Guo, Yang Gao, Yue Yin, Jun-Feng Huang, Jian Zhou, Jia Fan & Xin-Rong Yang. (2020) Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma. eBioMedicine 62, pages 103107.
Crossref
Crossref
Emily Miller & Lee Schwartzberg. (2020) Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA: It Is in the Blood. Current Treatment Options in Oncology 21:11.
Crossref
Crossref
Peng‐Xiang Wang, Yun‐Fan Sun, Kai‐Qian Zhou, Jian‐Wen Cheng, Bo Hu, Wei Guo, Yue Yin, Jun‐Feng Huang, Jian Zhou, Jia Fan, Tan To Cheung, Xu‐Dong Qu & Xin‐Rong Yang. (2020) Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single‐center, retrospective, propensity‐matched study. Clinical and Translational Medicine 10:3.
Crossref
Crossref
Sho Ikeda, Takahiro Kobayashi, Masaya Saito, Atsushi Komatsuda, Kumi Ubukawa, Yoshihiro Kameoka & Naoto Takahashi. (2019) Multiparameter Flow Cytometry for the Identification of Neoplastic Plasma Cells in POEMS Syndrome with IgG-kappa Gammopathy: Successful Treatment Using Lenalidomide and Dexamethasone. Internal Medicine 58:23, pages 3461-3468.
Crossref
Crossref
Heyjin Kim, Jae Won Yun, Seung-Tae Lee, Hee-Jin Kim, Sun-Hee Kim & Jong Won Kim. (2019) Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies. Annals of Laboratory Medicine 39:6, pages 515-523.
Crossref
Crossref
Ariana Rostami & Scott V. Bratman. (2017) Utilizing circulating tumour DNA in radiation oncology. Radiotherapy and Oncology 124:3, pages 357-364.
Crossref
Crossref
Lawrence J. Jennings, Maria E. Arcila, Christopher Corless, Suzanne Kamel-Reid, Ira M. Lubin, John Pfeifer, Robyn L. Temple-Smolkin, Karl V. Voelkerding & Marina N. Nikiforova. (2017) Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels. The Journal of Molecular Diagnostics 19:3, pages 341-365.
Crossref
Crossref
Thomas Kroneis, Emma Jonasson, Daniel Andersson, Soheila Dolatabadi & Anders Ståhlberg. (2017) Global preamplification simplifies targeted mRNA quantification. Scientific Reports 7:1.
Crossref
Crossref
Juan Liu, Jieni Cai, Hui Chen, Song Zhang & Jilie Kong. (2016) A label-free impedimetric cytosensor based on galactosylated gold-nanoisland biointerfaces for the detection of liver cancer cells in whole blood. Journal of Electroanalytical Chemistry 781, pages 103-108.
Crossref
Crossref
David H. Spencer, Bin Zhang & John Pfeifer. 2015. Clinical Genomics. Clinical Genomics
109
127
.